@BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally

Food and Healthcare Press Releases Monday August 5, 2019 12:00
TOKYO--5 Aug--Kyodo JBN- AsiaNet/InfoQuest

Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is now available to overseas users of CompactDry(TM). The launch of this application is part of the company's strategy of active investment in areas of new growth for the purpose of contributing to the development of overseas markets and quality control processes in relation to food hygiene.

(Logo1: https://kyodonewsprwire.jp/prwfile/release/M105074/201907319276/_prw_PI1fl_1Mft9204.jpg)
(Logo2: https://kyodonewsprwire.jp/img/201907319276-O2-u1982f9w)

Since August 2018, a limited number of Nissui Pharmaceutical's overseas customers have been testing and using @BactLAB(TM), a colony counter application developed exclusively for CompactDry(TM), an easy-to-use medium for measuring bacteria count and also the company's most important product for overseas customers. During this phase, it made several improvements to the application, such as faster counting of colonies, collecting and utilizing AI learning data, new convenience features and additional functions, all of which are now included in the released service.

@BactLAB(TM) official website:
https://www.nissui-pharm.co.jp/english/products/global/bactlab/
Application available at: Google Play / Apple Store / Amazon Appstore / Online Service
(Images1: https://kyodonewsprwire.jp/img/201907319276-O3-TipIpw4F)
@BactLAB(TM) Service Overview
  • Auto count with global cloud access, available on multiple devices (PC / Android / iPhone)
  • Cloud storage function of counted data
  • Exportable reports (in .csv file or .jpg file format)
  • Chat Bot support on the official website
* This service is an application designed exclusively for CompactDry(TM) customers.
* A Wi-Fi environment is recommended when using the smartphone app.
* Depending on the target image, there may be a counting error of up to 8%.
* A colony count result of "0" does not indicate a negative result.
* Nissui Pharmaceutical takes no responsibility for the analysis results provided by this service.
(Images2: https://kyodonewsprwire.jp/prwfile/release/M105074/201907319276/_prw_PI4fl_D1wtD48F.png)
* Google, Google Play, Android and other such marks are trademarks of Google Inc.
* Apple and the Apple logo are trademarks of Apple Inc. registered in the USA and other countries. App Store, AppleCare and iCloud are service marks of Apple Inc. (TM) and (R) Apple Inc. All rights reserved.
* Amazon and Amazon Web Service are trademarks or registered trademarks of Amazon.com, Inc. or its affiliates.
SOURCE: Nissui Pharmaceutical Co., Ltd.
AsiaNet 79935

Latest Press Release

Photo Release: Sri Trang Group donates 2 million gloves to assist efforts in fighting worldwide COVID-19 outbreak.

COVID-19 outbreak has spread tremendously to every continents with the blink of an eye. The outbreak has become a serious treat taken many lives and the number of infected individuals is increasing rapidly. On the 25th February 2020, Mr. Veerasith...

Cybernet Announces World#s First Antimicrobial Touch Glass on a Medical Grade Computer

Cybernet is excited to announce the world's first fully antimicrobial medical computer. Cybernet's medical grade computers have always featured a housing with antimicrobial properties baked directly into the resin, and now can offer a fully antimicrobial...

myONE(TM) set sights to enter condom market in Thailand through the mission to de-stimgatize condom use

myONE(TM), next-generation condoms, was officially launched on Valentine's Day. The brand is affiliated with the ONE(R) Condoms brand that was originally founded in Boston, USA in 2003 and subsequently acquired by Karex, the world's largest condom maker,...

IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs

IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope(TM) multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in...

Vakrangee มุ่งปฏิวัติบริการสุขภาพในชนบทของอินเดีย ผ่านบริการระบบแพทย์ทางไกลโดย vHealth by AETNA

- Vakrangee จับมือ vHealth by Aetna (a CVS Health Company) เพื่อให้บริการสุขภาพดิจิทัลระดับปฐมภูมิแก่ประชาชนในพื้นที่ชนบทของอินเดีย Vakrangee Limited (VL) ประกาศความร่วมมือเป็นพันธมิตรกับ vHealth by Aetna ในเครือ Aetna Inc, a CVS Health Company...

Related Topics